Health Sciences Acquisitions Corp
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $7.49
- Today's High:
- $12.4314
- Open Price:
- $11.75
- 52W Low:
- $7.49
- 52W High:
- $13.8
- Prev. Close:
- $13.31
- Volume:
- 503560
Company Statistics
- Market Cap.:
- $149.23 million
- Book Value:
- -0.619
- Revenue TTM:
- $0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- $0
- Profit Margin:
- 0%
- Return on Assets TTM:
- -1.68%
- Return on Equity TTM:
- 0%
Company Profile
Health Sciences Acquisitions Corp had its IPO on 2020-08-04 under the ticker symbol HSAQ.
The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. Health Sciences Acquisitions Corp has a staff strength of 0 employees.
Stock update
Shares of Health Sciences Acquisitions Corp opened at $11.75 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $7.49 - $12.43, and closed at $11.5.
This is a -13.6% slip from the previous day's closing price.
A total volume of 503,560 shares were traded at the close of the day’s session.
In the last one week, shares of Health Sciences Acquisitions Corp have increased by +14.77%.
Health Sciences Acquisitions Corp's Key Ratios
Health Sciences Acquisitions Corp has a market cap of $149.23 million, indicating a price to book ratio of 1.8126 and a price to sales ratio of 0.
In the last 12-months Health Sciences Acquisitions Corp’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Health Sciences Acquisitions Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Health Sciences Acquisitions Corp’s operating margin was 0% while its return on assets stood at -1.68% with a return of equity of 0%.
In Q4, Health Sciences Acquisitions Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Health Sciences Acquisitions Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.035 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Health Sciences Acquisitions Corp’s profitability.
Health Sciences Acquisitions Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -48.3264. Its price to sales ratio in the trailing 12-months stood at 0.
Health Sciences Acquisitions Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $68.08 million
- Total Liabilities
- $1.74 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Health Sciences Acquisitions Corp ended 2024 with $68.08 million in total assets and $0 in total liabilities. Its intangible assets were valued at $68.08 million while shareholder equity stood at $-6944676.00.
Health Sciences Acquisitions Corp ended 2024 with $0 in deferred long-term liabilities, $1.74 million in other current liabilities, in common stock, $-6945121.00 in retained earnings and $0 in goodwill. Its cash balance stood at $175161.00 and cash and short-term investments were $175161.00. The company’s total short-term debt was $0 while long-term debt stood at $0.
Health Sciences Acquisitions Corp’s total current assets stands at $299079.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $376930.00 and inventory worth $0.
In 2024, Health Sciences Acquisitions Corp's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Health Sciences Acquisitions Corp paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $11.5
- 52-Week High
- $13.8
- 52-Week Low
- $7.49
- Analyst Target Price
- $
Health Sciences Acquisitions Corp stock is currently trading at $11.5 per share. It touched a 52-week high of $13.8 and a 52-week low of $13.8. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $10.09 and 200-day moving average was $9.97 The short ratio stood at 4.62 indicating a short percent outstanding of 0%.
Around 3995.7% of the company’s stock are held by insiders while 5223.5% are held by institutions.
Frequently Asked Questions About Health Sciences Acquisitions Corp
Similar Industry Stocks (Healthcare Equipment & Supplies)
Most Active
Top Gainers
Top Losers
About
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.